PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
2026-05-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development
2026-05-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
2026-05-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Avance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership
2026-05-12T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats
2026-05-12T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
DNA 'barcodes' help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source
2026-05-12T    Biotechnology   Education   Health Care/Hospital   Higher Education 
Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery
2026-05-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape
2026-05-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
2026-05-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
2026-05-11T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.